Lineage Cell Therapeutics Virtual KOL Event
Lineage Cell Therapeutics, Inc.: OpRegen® - A Therapeutic Expert Discussion of Retinal Tissue Regeneration in Dry-AMD with Geographic Atrophy
Monday, June 8, 2020 @ 4:30pm ET / 1:30pm PT
Please join us for a call with therapeutic area experts as we discuss a case study of retinal tissue regeneration in Dry AMD with Geographic Atrophy. In its ongoing Phase 1/2a clinical study, Lineage has observed benefit in some patients, including increases in Best Corrected Visual Acuity (BCVA), reduction in the growth of geographic atrophy and increases in reading speed. The addition of signs of retinal tissue regeneration provides further support that OpRegen may be a viable treatment for the millions of individuals living with dry AMD, one of the leading causes of vision loss in the world.
Therapeutic Area Experts:
Jordi Monés, M.D., Ph.D., Director, Institut de la Màcula and Director, Principal Investigator and Founder, Barcelona Macula Foundation: Research for Vision
Michael S. Ip, M.D., Chief of Vitreoretinal Surgery Service, Doheny Eye Centers, UCLA
A live webcast of the event will be available at the link below or on the Events and Presentations section of Lineage’s website.
Audience Q&A will immediately follow the interview.